Login / Signup

Medical students' knowledge and awareness levels about biologics and biosimilars: the earlier the better?

Devrim Demir-DoraZinnet Şevval Aksoyalp
Published in: Expert opinion on biological therapy (2021)
Our study showed that medical students had inadequate knowledge about biosimilars. We suggest that to establish a positive attitude toward prescribing biosimilars, knowledge about biologics and biosimilars should be delivered to physicians early, while they are still medical students, by including this topic into the medical curriculum.
Keyphrases
  • medical students
  • healthcare
  • primary care
  • adverse drug